IGF1 and neoplasm: IGF-1 from tumor-initiating cells can prevent miR-122 expression in neighboring normal hepatocytes and thereby facilitate its intercellular transfer within exosomes, leading to low levels of antiproliferative miRNAs in hepatic cancer cells.